| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |